Full-Time

Clinical Research Coordinator II

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

Compensation Overview

$60k - $90k/yr

No H1B Sponsorship

Decatur, GA, USA

In Person

On-site position with regional commute; up to 10% travel within 100 miles.

Category
Biology & Biotech (1)
Required Skills
FDA Regulations
Word/Pages/Docs
Google Cloud Platform
Excel/Numbers/Sheets

Get referred to Care Access

See people who can refer or advise you

Requirements
  • Ability to understand and follow institutional SOPs
  • Excellent working knowledge of medical and research terminology
  • Excellent working knowledge of federal regulations, good clinical practices (GCP)
  • Operates independently for most study activities; escalates complex issues as needed
  • Ability to communicate and work effectively with a diverse team of professionals
  • Strong organizational, prioritization and leadership skills and capabilities with a strong attention to detail
  • Strong computer skills with demonstrated abilities using clinical trials database, IVR systems, electronic data capture, MS Word and Excel
  • Critical thinker and problem solver
  • Friendly, outgoing personality; maintain a positive attitude under pressure
  • High level of self-motivation and energy
  • Excellent professional writing and communication skills
  • Manages stakeholder communications; facilitates visits and meetings
  • Ability to work independently in a fast-paced environment with minimal supervision
  • Bachelor’s Degree preferred, or equivalent combination of education, training and experience
  • 3 years prior Clinical Research Coordinator experience required
  • Recent phlebotomy experience required
  • Prefer 1 year of experience as a Care Access Research Clinical Research Coordinator
  • Travel up to 10% regional travel
  • On-site position with regional commute requirements
  • Must be able to prescreen study candidates
  • Must be able to obtain informed consent per Care Access Research SOP
Responsibilities
  • Prioritize activities with specific regard to protocol timelines
  • Maintain adherence to FDA regulations and ICH guidelines in all aspects of conducting clinical trials
  • Maintain effective relationships with study participants and other Care Access Research personnel
  • Balances protocol needs with patient experience; proactively addresses concerns
  • Monitors quality metrics; prevents deviations; resolves queries quickly
  • Interact in a positive, professional manner with patients, representatives, investigators and Care Access Research personnel and management
  • Coordinate and attend pre-study site visits, site initiation visits, and monitor visits with clinical staff and Sponsor/CRO representatives
  • Mentors CRC I peers; provides onboarding and day‑to‑day guidance
  • Identify adverse events (AEs) and Serious Adverse Events (SAEs) and promptly notify Principal Investigator and Sponsor (where appropriate)
  • Moderate complexity; mixed visit types, active IP and AE/SAE workflows
  • Can operate as solo CRC onsite
  • Prescreen study candidates
  • Obtain informed consent per Care Access Research SOP
  • Complete visit procedures in accordance with protocol
  • Complete basic clinical procedures, such as blood draws, vital signs, ECGs, etc.
  • Review laboratory results, ECGs, and other test results (e.g., MRIs) for completeness and alert values, ensuring investigator review in a timely fashion
  • Discuss study medication, required procedures, eligibility criteria and impact on office flow with Investigator and site staff
  • Record data legibly and enter in real time on paper or e-source documents
  • Accurately record study medication inventory, medication dispensation, and patient compliance.
  • Resolve data management queries and correct source data within sponsor provided timelines
  • Assist regulatory personnel with completion and filing of regulatory documents.
  • Assist in the creation and review of source documents.
  • Assist with planning and creation of appropriate recruitment materials.
  • Assist in development of recruitment plan and obtain listing of potential candidates to contact from subject database.
  • Actively work with recruitment team in calling and recruiting subjects
  • Review and assess protocol (including amendments) for clarity, logistical feasibility
  • Ensure that all training and study requirements are met prior to trial conduct.
  • Communicate clearly verbally and in writing.
  • Anticipates needs; proposes solutions; manages change effectively.
  • Attend Investigator meetings as required.
  • Owns studies; prioritizes competing demands; mentors CRC I.
  • Ensure adequate supplies have arrived on site for protocol initiation (lab kits, study medication, specialized equipment, IVRS/EDC access and passwords)

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Get referred to Care Access

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart partnership expands recruitment via 4,700 stores, targeting underserved rural and minority communities.
  • Warsaw, Poland site launch strengthens European footprint amid rare disease trial growth in 2026.
  • FDA 2025 guidance boosts decentralized trials, amplifying Care Access's remote monitoring infrastructure.

What critics are saying

  • Walmart Healthcare Research Institute replicates Care Access model across stores, eroding patient pipeline by 2028.
  • Care Access Research lawsuit disrupts thousands of participants, halting enrollments through 2026 deadlines.
  • Warsaw site misses targets from Syneos Health competition and regulations within 12 months.

What makes Care Access unique

  • Care Access opens clinical research sites inside Walmart stores in Houston, Tyler, and Dalton starting Spring 2026.
  • Frontiers in Medicine study proves Care Access's community model achieves higher randomization rates than traditional sites.
  • Care Access deploys mobile clinics and Sites On Demand to deliver trials directly in local communities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-4%
SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations

Business Wire
Feb 27th, 2024
New Research Study For Patients With Ulcerative Colitis Now Available In Ogden, Utah

BOSTON--(BUSINESS WIRE)--Adults in the Ogden, Utah area with moderately to severely active ulcerative colitis (UC) may have the opportunity to join a research study assessing a new investigational medication. UC is the most common form of inflammatory bowel disease (IBD), affecting an estimated 5 million people worldwide. There is no known cure for UC, though new therapies have become available in recent years that offer patients improved treatment options. Current treatments for UC offer relief for many individuals, but some still face recurrent flare-ups or undesirable side effects. The ANTHEM-UC study from Janssen Research Development seeks to assess if an investigational pill could help those patients whose UC is not adequately managed by currently available therapies. “Ulcerative colitis is a lifelong condition that often gets worse over time, potentially causing severe flare-ups or hospitalization,” said Dr